Translation of new cancer treatments from pet dogs to humans (Q37059654)

18 August 2017

1 reference

title

Translation of new cancer treatments from pet dogs to humans (English)

1 reference

18 August 2017

Melissa Paoloni

1

1 reference

PubMed ID

18202698

18 August 2017

Chand Khanna

series ordinal

2

1 reference

PubMed ID

18202698

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

Nature Reviews Cancer

1 reference

18 August 2017

8

1 reference

18 August 2017

147-156

1 reference

18 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc2273

18 August 2017

0 references

cites work

Spontaneous and genetically engineered animal models; use in preclinical cancer drug development

1 reference

Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial

31 March 2020

1 reference

Ferret oncology: diseases, diagnostics, and therapeutics

31 March 2020

1 reference

Bovine papillomaviral gene expression in equine sarcoid tumours

31 March 2020

1 reference

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy

31 March 2020

1 reference

Comparative histopathology of grey-horse-melanoma and human malignant melanoma.

31 March 2020

1 reference

Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis

31 March 2020

1 reference

Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum

31 March 2020

1 reference

Lymphocyte reactivity to autochthonous tumor cells in dogs with spontaneous malignancies

31 March 2020

1 reference

Chemoimmunotherapy for canine lymphosarcoma.

31 March 2020

1 reference

Tumor vaccines for immunotherapy of canine lymphosarcoma

31 March 2020

1 reference

Cancer clues from pet dogs

31 March 2020

1 reference

High-grade prostatic intraepithelial neoplasia in dogs

31 March 2020

1 reference

Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans

31 March 2020

1 reference

The dog as a cancer model

31 March 2020

1 reference

Genome sequence, comparative analysis and haplotype structure of the domestic dog

31 March 2020

1 reference

Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors

31 March 2020

1 reference

Spontaneously occurring tumors of companion animals as models for human cancer

31 March 2020

1 reference

Genomics. A dog's breakfast?

31 March 2020

1 reference

Estimating the neutral rate of nucleotide substitution using introns

31 March 2020

1 reference

Comparative longevity of pet dogs and humans: implications for gerontology research

31 March 2020

2 references

31 March 2020

inferred from DOI database lookup

7 January 2021

based on heuristic

Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk

1 reference

Canine mammary cancer. II. Therapy and causes of death

31 March 2020

1 reference

Prognostic and predictive markers in canine tumours: rationale and relevance. A review

31 March 2020

1 reference

Using the canine genome to cure cancer and other diseases

31 March 2020

1 reference

Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes

31 March 2020

1 reference

Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers

31 March 2020

1 reference

Canine transitional cell carcinoma

31 March 2020

1 reference

Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma

31 March 2020

1 reference

The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy

31 March 2020

1 reference

Aberrations of the p53 tumor suppressor gene in various tumors in dogs

31 March 2020

1 reference

Mast cell tumors of the gastrointestinal tract in 39 dogs

31 March 2020

1 reference

Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours

31 March 2020

1 reference

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit

31 March 2020

1 reference

The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors

31 March 2020

1 reference

Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma

31 March 2020

1 reference

Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma

31 March 2020

1 reference

Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma.

31 March 2020

1 reference

Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma

31 March 2020

1 reference

Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?

31 March 2020

1 reference

Determining the significance of persistent lymphocytosis

31 March 2020

1 reference

Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma.

31 March 2020

1 reference

The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes

31 March 2020

1 reference

Spatial accuracy of fractionated IMRT delivery studies in canine paraspinal irradiation

31 March 2020

1 reference

Image guidance for precise conformal radiotherapy

31 March 2020

1 reference

Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993)

31 March 2020

1 reference

Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma

31 March 2020

1 reference

Why is cancer drug discovery so difficult?

31 March 2020

1 reference

Can the pharmaceutical industry reduce attrition rates?

31 March 2020

1 reference

Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma

31 March 2020

1 reference

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma

31 March 2020

1 reference

Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses

31 March 2020

1 reference

Genetic immunotherapy for cancer

31 March 2020

1 reference

The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model

31 March 2020

1 reference

Nebulized interleukin 2 liposomes: aerosol characteristics and biodistribution

31 March 2020

1 reference

Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases

31 March 2020

1 reference

Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.

31 March 2020

1 reference

Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer

31 March 2020

1 reference

Aerosol therapy for malignancy involving the lungs

31 March 2020

1 reference

Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers

31 March 2020

1 reference

Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs

31 March 2020

1 reference

Canine mast cell tumors express stem cell factor receptor.

31 March 2020

1 reference

Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.

31 March 2020

1 reference

A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period

31 March 2020

1 reference

The role of KIT in the management of patients with gastrointestinal stromal tumors

31 March 2020

1 reference

Gastrointestinal stromal tumour.

31 March 2020

1 reference

Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.

31 March 2020

1 reference

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

31 March 2020

1 reference

Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma

31 March 2020

1 reference

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

31 March 2020

1 reference

Clinical trials going to the dogs: canine program to study tumor treatment, biology

31 March 2020

1 reference

Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk

31 March 2020

1 reference

A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog.

31 March 2020

1 reference

Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review

31 March 2020

1 reference

Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC2273

1 reference

18 August 2017

1 reference

PubMed ID

18202698